Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.17% | 135.57 | 0.0% | $895.14m | |
| AMGN | Amgen, Inc. | 0.36% | 253.95 | 1.5% | $855.01m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 64.47 | 1.0% | $544.83m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.32% | 270.50 | 1.9% | $489.26m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.05% | 683.77 | 2.6% | $434.75m | |
| ILMN | Illumina, Inc. | 1.76% | 247.85 | 3.3% | $318.97m | |
| NVAX | Novavax, Inc. | -1.08% | 46.56 | 75.7% | $255.64m | |
| BIIB | Biogen, Inc. | 0.00% | 204.22 | 1.8% | $232.70m | |
| BNTX | BioNTech SE | 0.53% | 158.99 | 0.0% | $212.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 2.10 | 0.7% | $146.80m | |
| EXAS | EXACT Sciences Corp. | 2.21% | 50.96 | 17.7% | $131.02m | |
| TECH | Bio-Techne Corp. | 0.00% | 365.32 | 4.5% | $100.31m | |
| TXG | 10X Genomics, Inc. | 0.00% | 47.35 | 0.0% | $95.11m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 78.86 | 4.2% | $94.54m | |
| CRSP | CRISPR Therapeutics AG | 1.87% | 56.26 | 0.6% | $81.90m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. The firm products include rHuPH20, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.